PDL1 -SP- 263
Test Name
PDL1 -SP- 263
Home Collection, Lab Visit
Test Code
P0060a
Test Components/ Genes/ Parameters
PDL1 -SP- 263
Sample Report
Click on Icon
Test Information
Frequently Asked Questions
PDL1 -SP- 263
PD-L1 testing may be considered for patients with specific types of malignancies to predict response to specific immune checkpoint inhibitors.
The patient should carry the FFPE tissue or block of the Lung. This process is carried out by Breast Surgeon in the hospital
The test is recommended in Head & Neck Cancers, NSCLC, Urothelial Cancers to decide immunotherapy benefit to the patients
The test is performed by IHC technique
There is no risk associated with the test as biopsy will be taken by the trained surgeon in the hospital under anasthesia
PD-L1 22C3 IHC with CPS interpretation for pembrolizumab therapy